glimepiride has been researched along with Kidney Failure, Chronic in 1 studies
glimepiride: structure given in first source
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, YH | 1 |
| Lee, CJ | 1 |
| Lee, HS | 1 |
| Choe, EY | 1 |
| Lee, BW | 1 |
| Ahn, CW | 1 |
| Cha, BS | 1 |
| Lee, HC | 1 |
| Balkau, B | 1 |
| Kang, ES | 1 |
1 other study available for glimepiride and Kidney Failure, Chronic
| Article | Year |
|---|---|
Comparing kidney outcomes in type 2 diabetes treated with different sulphonylureas in real-life clinical practice.
Topics: Cohort Studies; Creatinine; Diabetes Mellitus, Type 2; Female; Gliclazide; Humans; Hypoglycemic Agen | 2015 |